MedTrace Logo

Randomized Controlled Study of the Traditional Percutaneous Coronary Intervention and Intervention Using Optical Coherence Tomography of Incomplete Stent Adhesion and Extent of the Formation of Neointima by Resolute Zotarolimus-eluting Stent Insertion

NCT01869842 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2013-06-05

No results posted yet for this study

Summary

Optical coherence tomography (OCT) after the stent procedure to improve the adhesion and expansion, or incomplete uncovered struts attached to the main track. OCT in clinical areas by improving the parameters of the best stent will be useful. However, for better results for optical coherence tomography in percutaneous interventions have little useful data on the role. Randomized controlled study of the traditional percutaneous coronary intervention and intervention using optical coherence tomography.

Conditions

Interventions

PROCEDURE

percutaneous coronary intervention

the traditional percutaneous coronary intervention by Resolute zotarolimus-eluting stent insertion

PROCEDURE

OCT-guided percutaneous coronary intervention

the percutaneous coronary intervention using optical coherence tomography by Resolute zotarolimus-eluting stent insertion

PROCEDURE

percutaneous coronary intervention

the traditional percutaneous coronary intervention by Resolute zotarolimus-eluting stent insertion

PROCEDURE

OCT-guided percutaneous coronary intervention

the percutaneous coronary intervention using optical coherence tomography by Resolute zotarolimus-eluting stent insertion

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2016-09-30
Completion
2016-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01869842 on ClinicalTrials.gov